Postoperative Mortality Rates After Surgery for Benign Prostatic Hyperplasia
Overview
This nationwide Finnish cohort study analyzed 39,320 patients undergoing surgery for benign prostatic hyperplasia (BPH) between 2004 and 2014. The overall 90-day postoperative mortality rate was 1.10%, with transurethral resection of the prostate (TURP) showing a higher mortality rate (1.16%) compared to laser vaporization (0.59%).
Background
Benign prostatic hyperplasia (BPH) commonly causes lower urinary tract symptoms in aging men, often necessitating surgical intervention despite advances in medical therapy. Surgical options include TURP, laser vaporization, and open prostatectomy, each with varying safety profiles. Understanding postoperative mortality and risk factors is crucial for optimizing treatment decisions, especially in elderly and comorbid patients.
Data Highlights
Procedure Type
Number of Procedures
90-Day Mortality Rate (%)
TURP
34,558
1.16
Laser Vaporization
3,715
0.59
Open Prostatectomy
1,047
Data not fully provided
Key Findings
A total of 39,320 patients undergoing BPH surgery were analyzed, with TURP being the most common procedure (88%).
The overall 90-day postoperative mortality rate was 1.10% (431 deaths).
Mortality after TURP was significantly higher (1.16%) than after laser vaporization (0.59%).
Most patients (70%) had no comorbidities (Charlson comorbidity index of 0), while 7% had atrial fibrillation and 9% had prostate cancer.
Procedures were mostly performed in high-volume centers, which may influence outcomes.
Clinical Implications
Surgeons should carefully consider patient comorbidities and age when selecting surgical treatment for BPH, as mortality risk varies by procedure type. Laser vaporization may offer a safer alternative to TURP in selected patients, particularly those at higher risk. High-volume centers appear to be the primary sites for these surgeries, potentially impacting postoperative outcomes.
Conclusion
This large nationwide study demonstrates that postoperative mortality after BPH surgery is low but varies by surgical technique, with laser vaporization associated with lower 90-day mortality than TURP. These findings support individualized surgical decision-making based on patient risk profiles.
References
Study Authors/Finland Institute for Health and Welfare/2024 -- Postoperative Mortality Rates in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Nationwide Cohort Analysis
